Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects With Drug-Resistant Epilepsy
Conditions
Interventions
Padsevonil
Placebo
Locations
148
United States
Ep0091 839
Chandler, Arizona, United States
Ep0091 810
Little Rock, Arkansas, United States
Ep0091 815
La Jolla, California, United States
Ep0091 801
San Francisco, California, United States
Ep0091 845
Washington D.C., District of Columbia, United States
Ep0091 809
Ocala, Florida, United States
Start Date
February 12, 2018
Primary Completion Date
January 30, 2020
Completion Date
January 30, 2020
Last Updated
December 19, 2023
NCT03893916
NCT07110688
NCT07010445
NCT06724029
Lead Sponsor
UCB Biopharma S.P.R.L.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions